W.R. Berkley Reinsurance & Monoline Excess — Ceded to Other Companies remained flat by 0.0% to $27.99M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 11.4%, from $31.60M to $27.99M. Over 4 years (FY 2021 to FY 2025), Reinsurance & Monoline Excess — Ceded to Other Companies shows relatively stable performance with a 0.6% CAGR.
An increase may signal a more conservative risk appetite or a strategic decision to reduce exposure to specific high-risk lines.
This represents the portion of premiums that the segment pays to other insurance or reinsurance companies to transfer a...
Standard industry metric for Ceded Premiums, used to assess risk retention strategies.
wrb_segment_reinsurance_monoline_excess_ceded_to_other_companies| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $109.41M | $105.34M | $113.52M | $126.41M | $111.96M |
| YoY Change | — | -3.7% | +7.8% | +11.4% | -11.4% |